Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -126.56M | $ -3.06 | 1 | 41.34M |
3/31/2025 | $ -58.01M | $ -1.41 | 1 | 41.07M |
12/31/2024 | $ -44.72M | $ -1.2 | 1 | 37.31M |
9/30/2024 | $ -17.46M | $ -0.43 | 1 | 40.63M |
6/30/2024 | $ -18.5M | $ -0.54 | 1 | 34.18M |
3/31/2024 | $ -93.9M | $ -2.8 | 1 | 33.5M |
12/31/2023 | $ 134.19M | $ 4.06 | 1 | 33.05M |
9/30/2023 | $ 111.17M | $ 3.34 | 1 | 33.28M |
6/30/2023 | $ 108.81M | $ 3.28 | 1 | 33.16M |
3/31/2023 | $ 126.64M | $ 3.91 | 1 | 32.37M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for ENTRADA THERAPEUTICS INC is calculated as follows: FCF [ $ -27.89M ] / (Shares WA [ 8M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -3.49 ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |